MATERIALS AND METHODS

Similar documents
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Clinical Guide - Suspected PE (Reviewed 2006)

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

Proper Diagnosis of Venous Thromboembolism (VTE)

Pulmonary Embolism. Thoracic radiologist Helena Lauri

Cover Page. The handle holds various files of this Leiden University dissertation.

Venous Thromboembolism (VTE)

Corresponding Author: Dr. Kishan A Bhgwat

Cover Page. The handle holds various files of this Leiden University dissertation

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism

Age-adjusted vs conventional D-dimer thresholds in the diagnosis of venous thromboembolism

Epidermiology Early pulmonary embolism

Diagnostic Algorithms in VTE

DVT and Pulmonary Embolus. Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre

Pulmonary Embolism..Diagnostic Approach and Algorithm. Tolulope Adesiyun Harvard Medical School, Year III Gillian Lieberman, MD

Provider Led Entity. CDI Quality Institute PLE Chest / Pulmonary Embolus AUC 07/31/2018

Radiation Exposure in Pregnancy. John R. Mayo UNIVERSITY OF BRITISH COLUMBIA

Audit of CT Pulmonary Angiogram in suspected pulmonary embolism patients

According to Their Presenting Syndromes*

8,9,10. Deep venous thrombosis (DVT) is clotting of blood in a deep vein of Pulmonary embolism

Audit of CT Pulmonary Angiogram in suspected pulmonary embolism patients

Too much medicine and venous thromboembolism: How can we make things Well again?

Simplified approach to investigation of suspected VTE

VTE General Background

Case 1. Technegas Case Studies. Prostate cancer. Finished treatment recently. Smoker. Angina. Presents sudden dyspnea and poorly defined chest pains.

Diagnosis of Venous Thromboembolism

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information

DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS

Reporting SPECT-VQ. Alp Notghi

Anticoagulation Forum: Management of Tiny Clots

Hayden Smith, PhD, MPH /\ v._

How to Diagnose Pulmonary Embolism anno 2014?

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

What You Should Know

New Criteria for Ventilation-Perfusion Lung Scan Interpretation: A Basis for Optimal Interaction with Helical CT Angiography 1

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting

Pulmonary Thromboembolism

Investigation and management of patients with pleuritic chest pain presenting to the accident and

Cover Page. The handle holds various files of this Leiden University dissertation

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital

Appendix to Gibson et al. Application of a decision rule and a D-dimer assay in the

State of the Art: Practical Approach for Diagosis of Pulmonary Embolism

Computed tomography pulmonary angiogram as a result of medical emergency team calls: a 5-year retrospective audit

From the Departments of Medicine, University of Ottawa, Ottawa, Canada, McMaster University, Hamilton, Canada, Dalhousie University, Halifax, Canada

SCINTIGRAPHY OF THE LUNGS THE VQ SCAN

CHAPTER 2 VENOUS THROMBOEMBOLISM

Chapter 1. Introduction

NIH Public Access Author Manuscript Am J Med. Author manuscript; available in PMC 2007 November 8.

PE Pathway. The charts are listed as follows:

Radiologic Features of The Pulmonary Embolus

Pulmonary embolism: assessment and imaging

M ortality from pulmonary embolic disease has

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

Imaging of acute pulmonary thromboembolism*

A low probability interpretation of a ventilation/

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients

Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis. By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan

University Journal of Medicine and Medical Specialities

D-dimer Value more than 3.6 μg/ml is Highly Possible Existence Deep Vein Thrombosis

Pulmonary Embolism Pathway

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust

October 2017 Pulmonary Embolism

Mabel Labrada, MD Miami VA Medical Center

Lung Cancer - Suspected

Diagnosis and management of acute pulmonary embolism Bobbie Morici, MSPAS, PA-C

Pulmonary Embolism Rule-out Criteria - Is it good enough?

Engin Ozakin, 1 Filiz Baloglu Kaya, 1 Nurdan Acar, 1 and Arif Alper Cevik 1,2. 1. Introduction

Deep Vein Thrombosis

Eenduidige diagnostiek van longembolie: progress after YEARS

Understanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal

Pulmonary Thromboembolism

Scanning the Literature

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Author(s): Rockefeller A. Oteng, M.D., University of Michigan

MDCT and Pulmonary Embolism. Heber MacMahon The University of Chicago Department of Radiology

ACR Appropriateness Criteria Suspected Lower Extremity Deep Vein Thrombosis EVIDENCE TABLE

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range

SCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW

Alveolar-Arterial Oxygen Gradient in the Assessment of Acute Pulmonary Embolism*

A 50-year-old woman with syncope

The Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT)

Triage D-Dimer Test. Pulmonary embolism? A rapid disposition can be a matter of life or death.

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

ORIGINAL INVESTIGATION. Assessing Clinical Probability of Pulmonary Embolism in the Emergency Ward. tools (leg vein ultrasonography 1-4 and plasma

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144

PULMONARY EMBOLISM/VTE CARE PROCESS MODEL

Findings in Patients Undergoing Computerised. Tomographic Pulmonary Angiography for Suspected. South Africa

Chapter 3. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

Pulmonary embolism? A rapid disposition can be a matter of life or death.

Mutidisciplinary cooperation on VTE prevention and managment

ED Diagnosis of DVT or tools to rule out DVT in your ED

8/16/2012. Pulmonary Embolism

Underuse of risk assessment and overuse of CTPA in patients with suspected pulmonary thromboembolism

Heart Health ESC Guidelines on the diagnosis and management of acute pulmonary embolism

ASSESSMENT OF LUNG PARENCHYMAL ABNORMALITIES

Inferior Vena Cava Filter for DVT

Transcription:

RETROSPECTIVE STUDY OF OPTIMISING THE USE OF COMPUTED TOMOGRAPHY PULMONARY ANGIOGRAPHY (CTPA) FOR THE DIAGNOSIS OF PULMONARY EMBOLISM IN PLACES WITH LIMITED RESOURCES P. V. Kalyan Kumar 1, Ramakrishna Gorantla 2, Ramakrishna Rachankonda 3, Jayakar Babu 4, Venu M 5 1Assistant Professor, Department of Pulmonary Medicine, Katuri Medical College, Guntur, Andhra Pradesh. 2Assistant Professor, Department of General Medicine, Katuri Medical College, Guntur, Andhra Pradesh. 3Professor, Department of Pulmonary Medicine, Katuri Medical College, Guntur, Andhra Pradesh. 4Professor and HOD, Department of Pulmonary Medicine, Katuri Medical College, Guntur, Andhra Pradesh. 5Assistant Professor, Department of Pulmonary Medicine, Katuri Medical College, Guntur, Andhra Pradesh. ABSTRACT BACKGROUND Aim of this study was to evaluate the use of computed tomography pulmonary angiography (CTPA) in the diagnostic evaluation of adult patients with a clinical suspicion of acute pulmonary embolism (PE) at our tertiary health centre and to determine whether pre-test probability assessment and D-dimer estimation lead to a more targeted approach to CTPA use in the local setting with limited resources. MATERIALS AND METHODS This was a two-year retrospective descriptive study of inpatients and outpatients referred to the pulmonology department for CTPA examination based on a clinical suspicion of acute pulmonary embolism (PE). Systematic sampling technique was employed in the selection of the patients who satisfied the inclusion criteria. The data was recorded in a Microsoft Excel spread sheet. Statistical analyses were performed using SPSS Statistics 24. RESULTS Of the 220 patients sampled, 54 examinations (24.7%) returned a positive result for acute pulmonary embolism (PE), 101 examinations (45.7%) revealed no abnormal radiologic findings and 65 examinations (29.6%) revealed diagnoses other than PE. In the low probability category, 79.1% of the CTPA examinations were normal and revealed no PE and 20.9% of the examinations revealed pulmonary embolism. In the intermediate category, the majority of the cases (65 %) revealed evidence of PE and 35% were negative for PE. In the high probability category, all the patients (100%) had CTPA evidence of pulmonary embolism. DISCUSSION The use of CTPA, without having established the pre-test probability of the disease, will continue to result in overuse of the test and in an unjustified increase of costs and radiation load. CONCLUSION Pretest probability along with D-dimers test can be used in the triage of patients for performing computed tomography pulmonary angiography (CTPA) evaluation in limited resource setting. KEYWORDS Computed Tomography Pulmonary Angiography (CTPA), Pulmonary Embolism (PE), Wells Clinical Probability Score, D-Dimer Test. HOW TO CITE THIS ARTICLE: Kumar PVK, Gorantla R, Rachankonda R, et al. Retrospective study of optimising the use of computed tomography pulmonary angiography (CTPA) for the diagnosis of pulmonary embolism in places with limited resources. Journal of Evolution of Research in Pulmonary Medicine 2016; Vol. 2, Issue 2, July-December 2016; Page: 16-21. BACKGROUND Acute pulmonary embolism (PE) is a common and sometimes fatal disease. Clinical evaluation and diagnostic testing is necessary before starting anticoagulation, which is the mainstay of therapy for PE. The approach to the evaluation should be efficient because avoiding delays in initiating therapy reduces morbidity and mortality from PE. 1,2 Financial or Other, Competing Interest: None. Submission 29-06-2016, Peer Review 15-11-2016, Acceptance 22-11-2016, Published 08-12-2016. Corresponding Author: Dr. P. V. Kalyan Kumar, Plot No. 304, Brindavan Residency Apartment, Brindavan Gardens, Opposite Teneega Restaurant, Brindavan Gardens, Guntur-522007, Andhra Pradesh. E-mail: drpvkalyan@hotmail.com Pulmonary embolism (PE) has a wide variety of presenting features, ranging from no symptoms to shock or sudden death. 3,4 The most common presenting symptom is dyspnoea followed by pleuritic pain and cough. However, many patients including those with large PE have mild or nonspecific symptoms or are asymptomatic. Thus, it is critical that a high level of suspicion be maintained such that clinically relevant cases are not missed. The most common symptoms in patients with PE were identified in the Prospective Investigation of Pulmonary Embolism Diagnosis II (PIOPED II) study. 5 They include the following: Dyspnoea at rest or with exertion (73 percent). Pleuritic pain (44 percent). Cough (37 percent). Orthopnoea (28 percent). Calf or thigh pain and/or swelling (44 percent). Wheezing (21 percent). Haemoptysis (13 percent). Journal of Evolution of Research in Pulmonary Medicine/ Vol. 2/ Issue 2/ July-December, 2016 Page 16

Common Presenting Signs on Examination Include, Tachypnoea (54 percent). Calf or thigh swelling, erythema, oedema, tenderness, palpable cords (47 percent). Tachycardia (24 percent). Rales (18 percent). Decreased breath sounds (17 percent). An accentuated pulmonic component of the second heart sound (15 percent). Jugular venous distension (14 percent). Fever, mimicking pneumonia (3 percent). D-dimer An elevated D-dimer alone is insufficient for the diagnosis of PE. In patients suspected of having PE, D-dimer levels are most useful when used in conjunction with clinical suspicion to facilitate clinical decision making for further testing. In general, for patients in whom PE is thought to be unlikely, a normal D-dimer (<500 ng/ml [fibrinogen equivalent units]) effectively excludes PE, and therefore, no further testing is required, including in patients who have had a prior PE, those with a delayed presentation, and women who are pregnant. 6 In contrast, an elevated D-dimer (>500 ng/ml [fibrinogen equivalent units]) should raise the suspicion for PE and prompt further testing in patients who have a low clinical probability of PE. Clinical Probability Testing Hospital identification numbers of the sampled cases were used to review the patient records which were searched for clinical parameters used to retrospectively work out Wells 7 pre-test probabilities. Of the pre-test clinical probability scores available, the Wells test was chosen for its simplicity and the fact that its parameters were easy to obtain. Diagnostic accuracy was greatest when CTPA was combined with prior clinical probability, as determined by the Wells criteria: Wells criteria and modified Wells criteria: clinical assessment for pulmonary embolism. Clinical symptoms of DVT (leg swelling, pain with palpation) 3.0 Other diagnosis less likely than pulmonary embolism 3.0 Heart rate >100 1.5 Immobilisation ( 3 days) or surgery in the previous four weeks 1.5 Previous DVT/PE 1.5 Haemoptysis 1.0 Malignancy 1.0 Probability Score Traditional clinical probability assessment (Wells criteria) High >6.0 Moderate 2.0 to 6.0 Low <2.0 Simplified clinical probability assessment (Modified Wells criteria) PE likely >4.0 PE unlikely 4.0 Patients with a low pre-test probability (Wells score <2) and a normal or low-probability V/Q scan had a less than 4 percent chance of having a PE. Patients with a high clinical probability (Wells score >6) and a high-probability scan had a 96 percent chance of having a PE. Patients with all other combinations were considered indeterminate and had probability of PE that ranged from 6 to 88 percent. Demographic profiles, including patients age and gender, were recorded. The charts were searched for records of symptoms and signs to suggest deep vein thrombosis (DVT) at or around the day of examination. Symptoms looked for include: Upper or lower limb pain Swelling and Discolouration of skin along with other Respiratory symptoms. Signs included upper or lower limb tenderness, positive Homans sign, prominent superficial veins and discolouration of the skin. Patients were then grouped into those with clinically suspected or confirmed deep vein thrombosis (DVT), those with no evidence of deep vein thrombosis (DVT) and a third category of unknown for the cases with insufficient data in relation to deep vein thrombosis (DVT). Heart-rate recordings on the day of the CTPA examination were reviewed and patients were grouped into those with heart-rates of 100 per minute or more and those with heartrates less than 100 per minute. Patients with heart-rates of at least 100 per minute were given 1.5 points. Chart reviews also included recorded evidence of immobilisation such as travel history, surgery in the preceding four weeks. Patients with a history of immobilisation were allocated 1.5 points. History of previous venous thromboembolic disease including DVT and PE were allocated 1.5 points. Recorded histories of haemoptysis were searched for and patients with a history of haemoptysis were allocated 1.0 point. Reviews further included history to suggest the presence of a recent malignancy or patients on palliative therapy. Patients with a positive history of malignancy were allocated 1.0 point. Points were tallied and patients who had scores more than > 4 were allocated the high clinical probability and scores 4.0 were allocated low clinical probability. Findings in relation to PE were reported as either PE present or not and whether acute or chronic. Acute PE was defined as a partial or complete filling defect of the pulmonary arterial system. Chronic PE was defined as the presence of direct pulmonary artery signs (complete or partial filling defect, the presence of an eccentric or calcified thrombus), signs related to pulmonary hypertension and/or signs of systemic collateral supply. CTPA results were reviewed and patients were grouped into confirmed PE, no abnormal findings or normal study and alternate diagnosis. Aim of Study To evaluate the use of computed tomography pulmonary angiography (CTPA) in the diagnostic evaluation of adult patients with a clinical suspicion of acute PE at our tertiary health centre and to determine whether pre-test probability Journal of Evolution of Research in Pulmonary Medicine/ Vol. 2/ Issue 2/ July-December, 2016 Page 17

assessment and D-dimer estimation lead to a more targeted approach to CTPA use in the local setting with limited resources. Objectives To determine the diagnostic yield of computed tomography pulmonary angiography (CTPA) in the local setting. To compare the pre-test probability scores to the outcomes of the computed tomography pulmonary angiography (CTPA) examinations. To compare both pre-test probability along with D-dimer test to the outcomes of the CTPA. MATERIALS AND METHODS Study Area The study was conducted at a tertiary health centre in Guntur, Andhra Pradesh, India. was recorded in a Microsoft Excel spread sheet. Statistical analyses were performed using SPSS Statistics 24. RESULTS A total of 412 computed tomography pulmonary angiography (CTPA) examinations were performed in the period 01/03/2014 to 01/03/2016. A total of 220 patients met the inclusion criteria. D-dimer results were reviewed and patients were categorised as positive, negative and unknown. The data was recorded in a Microsoft Excel spread sheet. Statistical analyses were performed using SPSS Statistics version 24. The patients sampled had a mean age of 41.30 with a standard deviation of 18.73. Of the sampled patients, 65.9% were female and males accounted for 34.1% (Fig 1). Study Design Retrospective descriptive study of patients. Study Population Patients referred to the pulmonology department for CTPA examination based on a clinical suspicion of acute pulmonary embolism (PE). The study population included both inpatients and outpatients attending the hospital. Statistical Design Retrospective two-year study and systematic sampling technique was employed in the selection of the patients who satisfied the inclusion criteria. The data was recorded in a Microsoft Excel spread sheet. Statistical analyses were performed using SPSS Statistics 24. Inclusion Criteria Adult patients (>14 years) referred for CTPA examination on the basis of a clinical suspicion of PE, for the first time, in the period 01/04/2014 to 01/04/2016 at a tertiary health centre. Figure 1. Gender Wise Distribution of Patients Of the 220 patients sampled, 54 examinations (24.7%) returned a positive result for acute pulmonary embolism (PE), 101 examinations (45.7%) revealed no abnormal radiologic findings and 65 examinations (29.6%) revealed diagnoses other than PE (Fig. 2). Exclusion Criteria 1. Younger patients (< 14 years) 2. Technically non-diagnostic or 3. Inadequate studies 4. Follow-up CTPAs performed on the same patients 5. CTPAs performed for indications other than PE. Ethical and Medico-Legal Aspects The study was a retrospective descriptive study of the patients that were subjected to CTPA on the basis of a clinical suspicion of PE. The study only commenced after full ethical approval was granted. It was reviewed and approved by the Medical Research and Ethics Committee (MREC) of the NTR University and Institutional approval. A total of 220 patients were selected from the study population using a systematic sampling technique following a random start. D-dimer results were reviewed and patients were categorised as positive, negative and unknown. The data Figure 2. Computed Tomography Pulmonary Angiography Results Wells clinical probability scores were worked out and assigned. One hundred thirty patients (59.2%) were in the low probability category, 69 patients (31.3 %) were in the Journal of Evolution of Research in Pulmonary Medicine/ Vol. 2/ Issue 2/ July-December, 2016 Page 18

intermediate probability category and twenty patients (9.5%) were in the high probability category (Fig:3). (19%) of intermediate probability category cases with negative D-dimers returned positive CTPA results. Chest Radiography A total of 45.2% of the sampled patients had abnormal chest x- rays, 15.2% had normal chest x-rays and chest x-ray results were unknown in 39.6% of the cases (Fig 5). Figure 3. Wells Clinical Probability Score In the low probability category, 79.1% of the computed tomography pulmonary angiography (CTPA) examinations were normal and revealed no pulmonary embolism (PE) and 20.9% of the examinations revealed pulmonary embolism (Fig 4). In the intermediate category, the majority of the cases (65%) revealed evidence of PE and 35% were negative for PE. In the high probability category, all the patients (100%) had CTPA evidence of pulmonary embolism (Fig 4). Common Findings Include: Atelectasis or pulmonary parenchymal abnormalities (46%), pleural effusion (47 percent). Usually Hampton s hump and Westermark's sign are rare, but should raise the suspicion for PE. Hampton s hump is a shallow, wedge-shaped opacity in the periphery of the lung, with its base against the pleural surface. Westermark's sign is the demonstration of a sharp cut-off of pulmonary vessels with distal hypoperfusion in a segmental distribution within the lung. These signs were positive only in 8% of the cases in our study. Figure 5. PIE Chart showing Chest Radiography Results Figure 4. Correlating Wells Probability with CTPA D-Dimer Of the sampled patients, 78.2% had D-dimer estimation performed and D -dimer test results were unknown or not done in 21.8%. Of the patients that had D-dimer tests performed, 55% were positive and 45% returned were negative (Table 1). Seventy-five percent (75%) of the patients with negative D-dimers had normal CTPA studies and PE was confirmed in 22%. Of the patients with positive D-dimer test results, 45.1% were normal with PE being confirmed in 44.6% (Table 1). D-Dimer Result Normal CTPA Result Confirmed Alternate PE Diagnosis Total Negative 58 17 2 77 Positive 43 42 10 95 Total 101 59 12 172 Table 1. D-Dimer Test Result VS. CTPA Result Patients in the low probability group, with negative D- dimer estimation, all returned negative computed tomography pulmonary angiography (CTPA) results. Nineteen percent Of the patients with normal CXRs, 74.4 % had no abnormal findings at CTPA and 15.3% had confirmed PE, 10.3% patients had alternate diagnosis. Of the patients with abnormal CXRs, 43.7% were negative (Fig 6) for PE and PE was confirmed in 33.1%, remaining 23.2% had alternate diagnosis (Fig 6). Patients with unknown CXRs, 51.3% had confirmed PE and 23.3% had no abnormalities at CTPA, remaining 25.4% had alternate diagnosis. Figure 6. Chest Radiography vs. CTPA Results Lower Limb Ultrasound Colour Venous Doppler results were negative in 16.3% of the patients, 15.2 % were positive and results were unknown in 68.5% of the cases. Of the patients with no current DVT, 82.7% Journal of Evolution of Research in Pulmonary Medicine/ Vol. 2/ Issue 2/ July-December, 2016 Page 19

returned normal CTPA. 17.3% of these cases (FIG 7) returning a positive PE result. In total, 81.4% of the patients with current DVT returned positive CTPA results in relation to PE and 18.6 % were (Fig 7) normal CTPA results. Figure 7. Lower limb DVT ultrasound vs. CTPA Alternate Diagnosis Figure 8. Pie chart showing Alternate Diagnosis DISCUSSION CTPA (computed tomography pulmonary angiography) is the investigation of choice in patients with a high clinical suspicion of pulmonary embolism (PE) and in those with pre-existing pulmonary disease. Clinical evaluation and diagnostic testing is necessary before starting anticoagulation, which is the mainstay of therapy for PE. The approach to the evaluation should be efficient because avoiding delays in initiating therapy reduces morbidity and mortality from pulmonary embolism (PE). Results from the current study showed that 59.2% of the CTPA examinations performed at our hospital were in the low probability pre-test category. These results suggest overuse of the CTPA technique and possibly poor choice in the selection of patients undergoing the CTPA without checking Wells pretest probability of the sampled cases, 31.3% were in intermediate probability and 9.5% were in the high probability category (Fig 3). In the low probability category, 79.1% of the CTPA examinations were normal and revealed no PE and 20.9% of the examinations revealed pulmonary embolism. In the intermediate category, the majority of the cases (65 %), revealed evidence of PE and 35% were negative for PE. In the high probability category, all the patients (100%) had CTPA evidence of pulmonary embolism. In total, 24.7% of the examinations performed were positive for PE (Figure 2). A total of 45.7% of the studies revealed no radiologic abnormality and a further 29.6% of the examinations revealed alternate diagnoses. The high percentage of alternate diagnoses underlines the fact that a more targeted approach is necessary in the evaluation of these patients and that possible pickup of an alternate diagnosis cannot justify CTPA use in low probability cases. The examinations that revealed alternate diagnoses showed cardiac disease in 37% of the cases. Congestive cardiac failure was the most common cardiac condition followed by rightsided heart failure. Pulmonary parenchymal disease was present in 33% of the examinations that revealed alternate diagnoses. Consolidation, pulmonary tuberculosis and interstitial lung disease were the most common lung parenchyma diseases. Pleural disease accounted for 20% of the alternate diagnoses and pleural effusion was the most common finding in these cases. Mediastinal disease accounted for 8% and airways disease for 2% of the alternate diagnoses in our study (Figure 8). D-dimer levels are elevated in plasma in the presence of an acute clot because of simultaneous activation of coagulation and fibrinolysis. A normal D-dimer level renders acute pulmonary embolism (PE) or deep venous thrombosis (DVT) unlikely. Although D-dimer is very specific for fibrin, the specificity of fibrin for VTE is poor because fibrin is produced in a wide variety of conditions, such as cancer, infection, inflammation, dissection of the aorta, and therefore D-dimer is not useful for confirming pulmonary embolism (PE). Data from a study conducted by van E N and colleagues, 8 CTPA can be withheld if Wells score is in low probability and a negative D- dimer result (efficiency) was estimated using fixed ( 500 µg/l) and age-adjusted (age 10 µg/l >50 years) D-dimer thresholds. The results of the most commonly adopted strategy to evaluate patients who are clinically suspected of having PE which show that the combination of the absence of definite risk factors and negative D-dimer test results could be used to substantially decrease the number of CTPA examinations performed in an emergency department. Of the patients that had D-dimer tests performed, 75% were positive and 25% returned negative (Table 1). Patients in the low probability group with negative D- dimer estimation all returned negative CTPA results. Eighteen percent of intermediate probability category cases with negative D-dimers returned positive CTPA results. The use of alternate interpretation of the Wells criteria, where scores of 4 or less are considered PE unlikely, and more than 4 PE likely, suggests that CTPAs can be safely withheld in the PE unlikely cases. The patients sampled had a mean age of 41.3 with a standard deviation of 18.73 and ranged from 14 to 72. Of the sampled patients, 65.9.6% were female and males accounted for 34.1% (Figure 1). Of the female patients, 50.9% were in the reproductive age group. As a result of the increased clinical use of CTPA, and its well-documented high radiation exposure, serious concerns have been raised about the possibility of increased incidence of cancers in the future. That is why it is important to select patients for CTPA correctly. Many studies provide evidence that suggests that a substantial number of CTPAs could be avoided simply by adhering to the information derived from clinical history and D-dimer test determination. In the current study, only 78.2% of the sampled patients had D-dimer estimation performed. The combination of negative D-dimers and a low probability Journal of Evolution of Research in Pulmonary Medicine/ Vol. 2/ Issue 2/ July-December, 2016 Page 20

category returned no PE positive CT examinations. This highlights the value of D-dimer estimation in the workup of these patients and the fact that more than 20% of the sampled cases did not have D-dimers performed clearly suggests that clinicians should be encouraged to use this D-dimer test in the triage of patients for performing computed tomography pulmonary angiography (CTPA) evaluation. The current study was a retrospective review of pre-test probability scores, which were worked out based on chart entries. The study population was heterogeneous, as it included in and outpatients, and chart entries prior to CTPA were of varying quality between these groups. The CT scans were reported by different observers of varying experience and this also served as a limiting factor for this study. CONCLUSIONS Pulmonary embolism (PE) remains a very challenging disease to diagnose. The myriad of alternate diagnoses clearly highlights the magnitude of the challenge clinicians are faced with in the clinical evaluation of the patients suspected of having PE. The results of the current study demonstrate that the majority of CTPA examinations performed at our institute had Wells low probability scores. These results suggest overuse of the CTPA technique and possibly poor choice in the selection of patients undergoing the examination. The results raise serious concerns about the radiation dose delivered to patients, which could have been avoided and further highlight the importance of correct patient selection prior to CTPA examination. The results further support the use of pre-test probability assessment in combination with D-dimer estimation prior to computed tomography pulmonary angiography (CTPA) evaluation in the local setting. CTPA is an accurate and readily available diagnostic test for the diagnosis or exclusion of pulmonary embolism (PE). However, use of CTPA, without having established the pre-test probability of the disease, will continue to result in overuse of the test and in an unjustified increase of costs and radiation load to the patients. REFERENCES 1. Smith SB, Geske JB, Maguire JM, et al. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest 2010;137(6):1382-90. 2. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033. 3. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990;263(20):2753-9. 4. Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no preexisting cardiac or pulmonary disease. Chest 1991;100(3):598-603. 5. Stein PD, Beemath A, Matta F, et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med 2007;120(10):871-9. 6. den Exter PL, van Es J, Erkens PM, et al. Impact of delay in clinical presentation on the diagnostic management and prognosis of patients with suspected pulmonary embolism. Am J Respir Crit Care Med 2013;187(12):1369-73. 7. van Es N, van der Hulle T, van Es J, et al. Wells rule and d- dimer testing to rule out pulmonary embolism: a systematic review and individual-patient data metaanalysis. Ann Intern Med 2016;165(4):253-61. Journal of Evolution of Research in Pulmonary Medicine/ Vol. 2/ Issue 2/ July-December, 2016 Page 21